Navigation Links
GenWay Clinical Laboratory receives accreditation from College of American Pathologists
Date:12/15/2009

GenWay Biotech, Inc. GenWay Clinical Laboratory, San Diego, California, has been awarded an accreditation by the College of American Pathologists (CAP), based on results of a recent onsite inspection.

The laboratory's director was advised of this national recognition and congratulated for the "excellence of the services being provided." GenWay Biotech Inc. GenWay Clinical Laboratory is one of nearly 7,000 CAP-accredited laboratories nationwide.

The CAP Laboratory Accreditation Program, begun in the early 1960s, is recognized by the federal government as being equal to or more stringent than the government's own inspection program.

During the CAP accreditation process, inspectors examine the laboratory's records and quality control of procedures for the preceding two years. CAP inspectors also examine the entire staff's qualifications, the laboratories equipment, facilities, safety program and record, as well as to the overall management of the laboratory. This stringent inspection program is designed to specifically ensure the highest standard of care for all laboratory patients.


'/>"/>

Contact: Sue Masaracchia-Roberts
800-323-4040 x7319
GenWay Biotech
Source:Eurekalert

Page: 1

Related biology news :

1. General tumor marker test now offered by GenWay clinical laboratory
2. GenWay Biotech obtains exclusive rights to AMDLs DR-70 cancer test in US and Canada
3. UAB bone center director wins distinguished service award from clinical pathology society
4. TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services
5. Magnetic nanotags spot cancer in mice earlier than methods now in clinical use
6. RadMD reaches 150th clinical trial
7. New cancer drug test promises safer and more effective clinical trials
8. IRSF announces funding of first clinical trial with disease-modifying therapy for Rett syndrome
9. Neurimmune Therapeutics Announces Advancement of Alzheimers Program into Preclinical Development
10. Antibody targeting of glioblastoma shows promise in preclinical tests, say Lombardi researchers
11. $20 million NIH grant to transform clinical research at UIC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2016)... NEW YORK , June 1, 2016 ... Biometric Technology in Election Administration and Criminal Identification to ... According to a recently released TechSci Research report, " ... Sector, By Region, Competition Forecast and Opportunities, 2011 - ... $ 24.8 billion by 2021, on account of growing ...
(Date:5/16/2016)... May 16, 2016   EyeLock LLC , a ... the opening of an IoT Center of Excellence in ... expand the development of embedded iris biometric applications. ... of convenience and security with unmatched biometric accuracy, making ... aside from DNA. EyeLock,s platform uses video technology to ...
(Date:5/3/2016)... 2016  Neurotechnology, a provider of high-precision biometric ... Biometric Identification System (ABIS) , a complete system ... ABIS can process multiple complex biometric transactions with ... fingerprint, face or iris biometrics. It leverages the ... MegaMatcher Accelerator , which have been used ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... STACS DNA ... Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a ... STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further ...
(Date:6/23/2016)... -- Andrew D Zelenetz , ... Published recently in Oncology & ... Andrew D Zelenetz , discusses the fact ... placing an increasing burden on healthcare systems worldwide, ... the patents on many biologics expiring, interest in ...
Breaking Biology Technology: